Donepezil

acetylcholinesterase (Cartwright blood group) ; Homo sapiens







333 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
251 15266045 Lack of pharmacokinetic or pharmacodynamic interaction between memantine and donepezil. 2004 Sep 3
252 15304241 Acetylcholinesterase inhibitors: novel activities of old molecules. 2004 Oct 2
253 15333988 [Pre-clinical evaluation of effects of acetylcholinesterase inhibition on the cerebral cholinergic neuronal system and cognitive function: PET study in conscious monkeys]. 2004 Sep 3
254 15341532 Acetylcholinesterase inhibitors increase ADAM10 activity by promoting its trafficking in neuroblastoma cell lines. 2004 Sep 1
255 15496218 Steady-state pharmacokinetics, pharmacodynamics and tolerability of donepezil hydrochloride in hepatically impaired patients. 2004 Nov 1
256 15544502 An overview of the current and novel drugs for Alzheimer's disease with particular reference to anti-cholinesterase compounds. 2004 1
257 15544507 New classes of AChE inhibitors with additional pharmacological effects of interest for the treatment of Alzheimer's disease. 2004 1
258 15558381 Donepezil as an adjuvant to constraint-induced therapy for upper-limb dysfunction after stroke: an exploratory randomized clinical trial. 2004 Jul 1
259 15567429 Novel neuronal targets for the acetylcholinesterase inhibitor donepezil. 2004 Dec 2
260 22034396 Pharmacotherapy of mild cognitive impairment. 2004 Dec 1
261 12604096 Sex dimorphisms in the cognitive-enhancing action of the Alzheimer's drug donepezil in aged Rhesus monkeys. 2003 Mar 2
262 12688400 Acetylcholinesterase inhibitor (donepezil hydrochloride) reduces heart rate variability. 2003 Jan 2
263 12716251 Co-use of donepezil and hypnotics among Alzheimer's disease patients living in the community. 2003 Apr 2
264 12955395 Study of donepezil binding to serum albumin by capillary electrophoresis and circular dichroism. 2003 Nov 1
265 13129577 A conformational restriction approach to the development of dual inhibitors of acetylcholinesterase and serotonin transporter as potential agents for Alzheimer's disease. 2003 Oct 1 2
266 14501021 Progress toward a high-affinity allosteric enhancer at muscarinic M1 receptors. 2003 2
267 14535624 Potencies and selectivities of inhibitors of acetylcholinesterase and its molecular forms in normal and Alzheimer's disease brain. 2003 1
268 14561111 Effects of donepezil on cognitive functioning in Down syndrome. 2003 Nov 1
269 14594748 Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease. 2003 Nov 1
270 14687441 Strategies for continued successful treatment of Alzheimer's disease: switching cholinesterase inhibitors. 2003 2
271 15088511 [Acetylcholinesterase inhibitors]. 2003 Jul 2
272 15352644 Treatment of opiate-related sedation: utility of the cholinesterase inhibitors. 2003 May-Jun 2
273 16191240 Patient populations in clinical studies of donepezil in vascular dementia. 2003 1
274 11852291 Therapeutic effects of an acetylcholinesterase inhibitor (donepezil) on memory in Wernicke-Korsakoff's disease. 2002 Jan-Feb 1
275 11888054 Determination of donepezil, an acetylcholinesterase inhibitor, in human plasma by high-performance liquid chromatography with ultraviolet absorbance detection. 2002 Mar 5 1
276 12083745 Research and development of donepezil hydrochloride, a new type of acetylcholinesterase inhibitor. 2002 May 5
277 12094822 Efficacy and safety of rivastigmine in patients with Alzheimer's disease who failed to benefit from treatment with donepezil. 2002 1
278 12105320 Donepezil and flight simulator performance: effects on retention of complex skills. 2002 Jul 9 1
279 12134305 [Nicotinic Receptor, galantamine and Alzheimer disease]. 2002 Jun 1-15 1
280 12139367 The tolerability and safety of cholinesterase inhibitors in the treatment of dementia. 2002 Jun 1
281 12162759 Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors. 2002 1
282 12240787 Rivastigmine for the treatment of dementia and visual hallucinations associated with Parkinson's disease: a case series. 2002 1
283 12450245 The cholinergic approach for the treatment of vascular dementia: evidence from pre-clinical and clinical studies. 2002 Oct-Nov 1
284 12454562 Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease. 2002 Dec 3
285 12548360 Cerebrospinal fluid levels of biomarkers and activity of acetylcholinesterase (AChE) and butyrylcholinesterase in AD patients before and after treatment with different AChE inhibitors. 2002 Sep 1
286 11171913 Effect of donepezil on brain acetylcholinesterase activity in patients with AD measured by PET. 2001 Feb 13 3
287 11226635 Differential increase in cerebrospinal fluid-acetylcholinesterase after treatment with acetylcholinesterase inhibitors in patients with Alzheimer's disease. 2001 Mar 16 1
288 11226748 Donepezil-induced REM sleep augmentation enhances memory performance in elderly, healthy persons. 2001 Feb 1
289 11255446 Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease. 2001 Mar 1
290 11369163 Donepezil in the treatment of opioid-induced sedation: report of six cases. 2001 May 1
291 11394735 Structure-based 3D QSAR and design of novel acetylcholinesterase inhibitors. 2001 May 1
292 11441435 Cholinergic modulation of speed of early information processing: the effect of donepezil on inspection time. 2001 Jun 1
293 11589922 Cerebrospinal fluid acetylcholinesterase activity after long-term treatment with donepezil and rivastigmina. 2001 Nov 3
294 11669506 Maintaining cognitive function in Alzheimer disease: how effective are current treatments? 2001 Aug 1
295 11689088 Synthesis and screening for antiacetylcholinesterase activity of (1-benzyl-4-oxopiperidin-3-ylidene)methylindoles and -pyrroles related to donepezil. 2001 Nov 8 2
296 11782241 Donepezil in schizophrenia--is it helpful? An experimental design case study. 2001 Dec 1
297 11830754 Donepezil for Alzheimer's disease: pharmacodynamic, pharmacokinetic, and clinical profiles. 2001 Winter 3
298 19811047 Use of acetylcholinesterase inhibitors in Alzheimer's disease. 2001 Sep 1
299 10637365 Molecular modelling and QSAR of reversible acetylcholines-terase inhibitors. 2000 Mar 1
300 10641971 Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of Alzheimer's disease. 2000 Jan 2